Metabolic syndrome rates in older patients with severe mental illness after five years of follow-up and the association with mortality
Autor: | Mardien L. Oudega, Max L. Stek, Didi Rhebergen, Paul D. Meesters, Nadine P.G. Paans, Daniel S. van Grootheest, Caroline M. Sonnenberg, Hugo W. Konz, Cora J. Kerssens, Hannie C. Comijs, Annemiek Dols, Emma J. de Louw |
---|---|
Přispěvatelé: | Psychiatry, APH - Mental Health, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Neurology, APH - Aging & Later Life |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
Pediatrics medicine.medical_specialty 03 medical and health sciences 0302 clinical medicine Older patients Diabetes mellitus Medicine Outpatient clinic Humans Aged Netherlands Aged 80 and over Metabolic Syndrome 030214 geriatrics business.industry Mental Disorders Middle Aged Mental illness medicine.disease Mental health Psychiatry and Mental health Logistic Models Sample size determination Female Geriatrics and Gerontology Metabolic syndrome business Follow-Up Studies |
Zdroj: | International Journal of Geriatric Psychiatry, 34(2), 333-336. John Wiley and Sons Ltd de Louw, E J, Paans, N P G, Sonnenberg, C M, Konz, H, Meesters, P D, van Grootheest, D, Oudega, M L, Rhebergen, D, Kerssens, C, Comijs, H C, Stek, M L & Dols, A 2019, ' Metabolic syndrome rates in older patients with severe mental illness after five years of follow-up and the association with mortality ', International Journal of Geriatric Psychiatry, vol. 34, no. 2, pp. 333-336 . https://doi.org/10.1002/gps.5025 |
ISSN: | 0885-6230 |
DOI: | 10.1002/gps.5025 |
Popis: | Objectives: To establish the course of metabolic syndrome (MS) rates in older patients with severe mental illness (SMI) after 5-year follow-up and evaluate whether MS at baseline is associated with mortality or diabetes at follow-up. Methods: Patients (>60 years of age) with SMI (N = 100) were included at a specialized mental health outpatient clinic. Metabolic parameters were collected from patients' medical files at baseline and after 5-year follow-up. Results: Follow-up data were available of 98 patients (98%); nine patients had died. Parameters of MS were available of 76 patients; 34.2% were diagnosed with MS. This was not significantly different compared with baseline (46.1%). MS at baseline was not significantly associated with mortality or development of diabetes at follow-up. Conclusions: In older patients with SMI, the rates of MS may reach a plateau. Screening for MS in older patients treated at a specialized mental health outpatient clinic may generate attention for their somatic health and treatment for the components of MS that may in turn have a positive effect on their outcome. However, further research with larger sample sizes is needed in order to confirm these findings. |
Databáze: | OpenAIRE |
Externí odkaz: |